Tuesday, June 28, 2011

Zofron




Zofron may be available in the countries listed below.


Ingredient matches for Zofron



Ondansetron

Ondansetron is reported as an ingredient of Zofron in the following countries:


  • Greece

International Drug Name Search

Wednesday, June 22, 2011

Cromatonbic Ferro




Cromatonbic Ferro may be available in the countries listed below.


Ingredient matches for Cromatonbic Ferro



Ferrous Lactate

Ferrous Lactate is reported as an ingredient of Cromatonbic Ferro in the following countries:


  • Spain

International Drug Name Search

Sunday, June 19, 2011

Methoxsalen




In the US, Methoxsalen (methoxsalen systemic) is a member of the drug class psoralens and is used to treat Cutaneous T-cell Lymphoma and Psoriasis.

US matches:

  • Methoxsalen Hard-Gelatin Capsules

  • Methoxsalen Lotion

  • Methoxsalen Soft-Gelatin Capsules

  • Methoxsalen

  • Methoxsalen Injection

  • Methoxsalen Topical

Scheme

USP

ATC (Anatomical Therapeutic Chemical Classification)

D05AD02,D05BA02

CAS registry number (Chemical Abstracts Service)

0000298-81-7

Chemical Formula

C12-H8-O4

Molecular Weight

216

Therapeutic Categories

Dermatological agent: Melanizing

Photosensitizing agent

Chemical Name

7H-Furo[3,2-g][1]benzopyran-7-one, 9-methoxy-

Foreign Names

  • Methoxsalen (German)
  • Méthoxsalène (French)

Generic Names

  • Methoxsalen (OS: BAN, JAN)
  • Méthoxsalène (OS: DCF)
  • 8-MOP (IS)
  • 9-Methoxypsoralen (IS)
  • Ammoidin (IS)
  • Xanthotoxin (IS)
  • Methoxsalen (PH: JP XIV, USP 32)

Brand Names

  • 8-MOP
    Valeant, United States


  • Delsoralen
    Darya-Varia, Indonesia


  • Deltasoralen
    Delta, Ireland


  • Dermox
    Mex-América, Mexico


  • Geralen
    Gerot, Austria; Gerot, Poland


  • Geroxalen
    Liba, Turkey; Sanofi-Aventis, Netherlands


  • Macsoralen
    Mac, India


  • Meladinina
    Chinoin, Costa Rica; Chinoin, Dominican Republic; Chinoin, Guatemala; Chinoin, Mexico; Chinoin, Nicaragua; Chinoin, Panama; Chinoin, El Salvador


  • Meladinine
    CLS Pharma, Vietnam; Galderma, Germany; Memphis Chemical Company, Ethiopia


  • Méladinine
    CLS Pharma, Tunisia; DB, France


  • Melanocyl
    Franco-Indian, India


  • Melaoline
    Uni-Pharma, Greece


  • Metoxaleno USP
    Map, Peru


  • Mopsalem
    California, Colombia


  • Mopsoralen
    Kela, Belgium


  • Neo-Meladinine
    Memphis, Oman; Memphis Chemical Company, Ethiopia


  • Oxsoralen
    Galderma, Spain; Gerot, Austria; Gerot, Czech Republic; Gerot, Hungary; Gerot, Poland; ICN, United Arab Emirates; ICN, Bahrain; ICN, Jordan; ICN, Kuwait; ICN, Lebanon; ICN, Qatar; ICN, Saudi Arabia; ICN, Sudan; ICN, Yemen; ICN Switzerland, Oman; Lannacher, Russian Federation; Pharmaco, South Africa; Raffo, Chile; Surya Dermato Medica, Indonesia; Taisho Yakuhin, Japan; Valeant, Argentina; Valeant, Brazil; Valeant, Canada; Valeant, Hong Kong; Valeant, Sri Lanka; Valeant, Mexico; Valeant, Singapore; Valeant, United States


  • Oxsoralen-Ultra
    Valeant, Taiwan


  • Triloxar
    Farmindustria, Peru


  • Ultrameladinine
    Memphis, Oman


  • Uvadex
    Janssen-Cilag, Switzerland; Therakos, Germany; Therakos, United States


  • Vitpso
    Orva, Turkey

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
USPPharmacopoeia of the United States

Click for further information on drug naming conventions and International Nonproprietary Names.

Novadral




Novadral may be available in the countries listed below.


Ingredient matches for Novadral



Norfenefrine

Norfenefrine is reported as an ingredient of Novadral in the following countries:


  • Turkey

International Drug Name Search

Friday, June 17, 2011

rubella virus vaccine, live Subcutaneous


roo-BELL-a VYE-rus VAX-een, lyve


Commonly used brand name(s)

In the U.S.


  • Meruvax II

Available Dosage Forms:


  • Powder for Solution

  • Injectable

Therapeutic Class: Vaccine


Uses For rubella virus vaccine, live


Rubella virus vaccine live is an active immunizing agent used to prevent infection by the rubella virus. It works by causing your body to produce its own protection (antibodies) against the virus infection.


Rubella (also known as German measles) is a serious infection that causes miscarriages, stillbirths, or birth defects in unborn babies when pregnant women get the disease. While immunization against rubella is recommended for everyone, it is especially important for women of child-bearing age.


Immunization against rubella is also important for employees in medical facilities, adolescents and adult men, persons traveling outside the U.S., and all children 12 months of age and older, including school-aged children.


Immunization against rubella is not recommended for infants less than 12 months of age, because antibodies they received from their mothers before birth may interfere with the effectiveness of the vaccine. Children who were immunized against rubella before 12 months of age should be immunized again.


You can be considered immune to rubella only if you received rubella vaccine on or after your first birthday and have the medical record to prove it, or if you have had a blood test showing immunity to rubella. A past history of having a rubella infection does not prove immunity, because the signs of rubella infection are not reliable enough to be certain that you have had the disease.


Since vaccination with rubella vaccine may not provide protection for everyone, you may want to ask your doctor to check your immunity to the rubella virus 6 to 8 weeks following your vaccination. This may be especially important if you are a woman of child-bearing age who is likely to become pregnant in the future.


This vaccine is to be administered only by or under the supervision of your doctor or other health care professional.


Before Using rubella virus vaccine, live


In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to rubella virus vaccine, live or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Use is not recommended for infants less than 12 months of age. rubella virus vaccine, live has been tested in older infants and children and, in effective doses, has not been shown to cause different side effects or problems than it does in adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this vaccine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Receiving this vaccine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Aclarubicin

  • Adalimumab

  • Aldesleukin

  • Alemtuzumab

  • Altretamine

  • Amonafide

  • Amsacrine

  • Asparaginase

  • Azacitidine

  • Azathioprine

  • Bleomycin

  • Broxuridine

  • Busulfan

  • Capecitabine

  • Carboplatin

  • Carmustine

  • Certolizumab Pegol

  • Chlorambucil

  • Cisplatin

  • Cladribine

  • Cyclophosphamide

  • Cytarabine

  • Cytarabine Liposome

  • Dacarbazine

  • Dactinomycin

  • Daunorubicin

  • Daunorubicin Citrate Liposome

  • Decitabine

  • Docetaxel

  • Doxifluridine

  • Doxorubicin Hydrochloride

  • Doxorubicin Hydrochloride Liposome

  • Edatrexate

  • Eflornithine

  • Epirubicin

  • Estramustine

  • Etanercept

  • Etoposide

  • Everolimus

  • Fingolimod

  • Floxuridine

  • Fludarabine

  • Fluorouracil

  • Fotemustine

  • Gallium Nitrate

  • Gemcitabine

  • Golimumab

  • Hydroxyurea

  • Idarubicin

  • Ifosfamide

  • Irinotecan

  • Lomustine

  • Mechlorethamine

  • Melphalan

  • Mercaptopurine

  • Methotrexate

  • Mitolactol

  • Mitomycin

  • Mitotane

  • Mitoxantrone

  • Mycophenolic Acid

  • Oxaliplatin

  • Paclitaxel

  • Pegaspargase

  • Pentostatin

  • Pipobroman

  • Pirarubicin

  • Plicamycin

  • Procarbazine

  • Raltitrexed

  • Rilonacept

  • Rituximab

  • Sirolimus

  • Streptozocin

  • Tacrolimus

  • Teceleukin

  • Tegafur

  • Temsirolimus

  • Teniposide

  • Thioguanine

  • Thiotepa

  • Topotecan

  • Treosulfan

  • Trimetrexate

  • Trofosfamide

  • Uracil Mustard

  • Ustekinumab

  • Vinblastine

  • Vincristine

  • Vincristine Liposome

  • Vindesine

  • Vinorelbine

Receiving this vaccine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abatacept

  • Leflunomide

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Immune deficiency condition (or family history of)—Condition may increase the chance and severity of side effects of the vaccine and/or may decrease the useful effects of the vaccine

  • Severe illness with fever—The symptoms of the condition may be confused with the possible side effects of the vaccine

Proper Use of rubella virus vaccine, live


Dosing


The dose of rubella virus vaccine, live will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of rubella virus vaccine, live. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For prevention of rubella:
      • Adults and children 12 months of age and older—One dose injected under the skin.

      • Children up to 12 months of age—Use is not recommended.



Precautions While Using rubella virus vaccine, live


Do not become pregnant for 3 months after receiving rubella vaccine without first checking with your doctor. There is a chance that this vaccine may cause birth defects.


Tell your doctor that you have received this vaccine:


  • if you are to receive a tuberculin skin test within 4 to 6 weeks after receiving this vaccine. The results of the test may be affected by this vaccine.

  • if you are to receive blood transfusions or other blood products within 2 weeks after receiving this vaccine.

  • if you are to receive gamma globulin or other immune globulins within 2 weeks after receiving this vaccine.

rubella virus vaccine, live Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Symptoms of allergic reaction
  • Difficulty in breathing or swallowing

  • hives

  • itching, especially of feet or hands

  • reddening of skin, especially around ears

  • swelling of eyes, face, or inside of nose

  • unusual tiredness or weakness (sudden and severe)

Check with your doctor as soon as possible if any of the following side effects occur:


Less common
  • Pain or tenderness of eyes

Rare
  • Bruising or purple spots on skin

  • confusion

  • convulsions (seizures)

  • headache (severe or continuing)

  • pain, numbness, or tingling of hands, arms, legs, or feet

  • stiff neck

  • unusual irritability

  • vomiting

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Burning or stinging at place of injection

  • skin rash

  • swelling of glands in neck

Less common
  • Aches or pain in joints

  • headache (mild), sore throat, runny nose, or fever

  • itching, swelling, redness, tenderness, or hard lump at place of injection

  • nausea

  • vague feeling of bodily discomfort

The above side effects (especially aches or pain in joints) are more likely to occur in adults, particularly women.


Some of the above side effects may not occur until 1 to 4 weeks after immunization and usually last less than 1 week. Aches or pain in joints may not occur until 1 to 10 weeks after immunization, and usually lasts less than 1 week. Check with your doctor if this side effect continues or is bothersome.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: rubella virus vaccine, live Subcutaneous side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More rubella virus vaccine, live Subcutaneous resources


  • Rubella virus vaccine, live Subcutaneous Side Effects (in more detail)
  • Rubella virus vaccine, live Subcutaneous Use in Pregnancy & Breastfeeding
  • Rubella virus vaccine, live Subcutaneous Drug Interactions
  • Rubella virus vaccine, live Subcutaneous Support Group
  • 0 Reviews for Rubella virus vaccine, live Subcutaneous - Add your own review/rating


Compare rubella virus vaccine, live Subcutaneous with other medications


  • Rubella Prophylaxis

Wednesday, June 15, 2011

Methimazole




In the US, Methimazole (methimazole systemic) is a member of the drug class antithyroid agents and is used to treat Hyperthyroidism.

US matches:

  • Methimazole

Ingredient matches for Methimazole



Thiamazole

Methimazole (BAN) is also known as Thiamazole (Rec.INN)

International Drug Name Search

Glossary

BANBritish Approved Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Nasentropfen E Hexal




Nasentropfen E Hexal may be available in the countries listed below.


Ingredient matches for Nasentropfen E Hexal



Xylometazoline

Xylometazoline hydrochloride (a derivative of Xylometazoline) is reported as an ingredient of Nasentropfen E Hexal in the following countries:


  • Germany

International Drug Name Search

Thursday, June 9, 2011

Terasin




Terasin may be available in the countries listed below.


Ingredient matches for Terasin



Terazosin

Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Terasin in the following countries:


  • Taiwan

International Drug Name Search

Wednesday, June 8, 2011

Kitapram




Kitapram may be available in the countries listed below.


Ingredient matches for Kitapram



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Kitapram in the following countries:


  • Taiwan

International Drug Name Search

Monday, June 6, 2011

Pantoprazol Genericon




Pantoprazol Genericon may be available in the countries listed below.


Ingredient matches for Pantoprazol Genericon



Pantoprazole

Pantoprazole is reported as an ingredient of Pantoprazol Genericon in the following countries:


  • Austria

International Drug Name Search

Wednesday, June 1, 2011

Piperazina Merey




Piperazina Merey may be available in the countries listed below.


Ingredient matches for Piperazina Merey



Piperazine

Piperazine hexahydrate (a derivative of Piperazine) is reported as an ingredient of Piperazina Merey in the following countries:


  • Colombia

International Drug Name Search